Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome

Annals of Saudi Medicine

Volumn 25, Issue 5, 2005, Pages 380-384

  Al Akash, Samhar ^a   Al Makdama, Abdulkarim ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; LEVAMISOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; STOMATITIS;

EID: 27944507780     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2005.380     Document Type: Review

References (27)

1. Koskimies O, Vilska J, Rapola J, Hallman N. Long-term outcome of primary nophrotic syndrome. Arch Dis Child. 1982;57:544-548.
2. Tarshish P, Tobin JN, Bernstein J, Edelmann CMJ. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769-776.
3. Durkan AM, Hodson EM, Willis NA, Craig JC. Immunosuppressive agents in chidhood nephrotic syndrome: A meta-analysis of randomized controlled trials. Kidney Int. 2001;59:1919-1927.
4. Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation. Transplant Proc. 1997;29:340-341.
5. Kapitsinou PP, Boletis JN, Skopouli FN, Boki KA, Moutsopoulos HM. Lupus nephritis: treatment with mycophenoalte mofetil. Rheumatology Oxford. 2004;43:377-380.
6. Boumpas DT. Sequential therapies with intravenous cyclophosphamide and oral mycophenolate mofetil or azathioprine are efficacious and safe in proliferative lupus nephritis. Clin Exp Rheumatol. 2004;22:276-277.
7. Ding L, Zhao M, Zou W, Liu Y, Wang H. Mycophenolate mofetil combined with prednisone for diffuse proliferative nephritis. Lupus. 2004;13:113-118.
8. Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplt. 2002;17:2011-2013.
9. Montané B, Abitbol C, Chander J, Strauss J, Zilleruelo G. Novel therapy of focal glomerulio-sclerosis with mycophenolate mofetil and angiotensin blockade. Pediatr Nephrol. 2003;18:772-777.
10. Kveder R. Therapy-resistant focal and segmental glomerulosclerosis. Nephrol Dial Transplant. 18 suppl 5 2003;v34-v37.
11. Barletta G, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol. 2003;18:833-837.
12. Choi MJ, Eustace JA, Gimenez LF, Atta MG, School PJ, Sothinathan R, Briggs WA. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int. 2002;61:1098-1114.
13. Cattran DC. Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy. Semin Nephrol. 2003;23:272-277.
14. Miller G, Zimmerman R 3rd, Radhakrishnan J, Appel G. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis. 2000;36:250-256.
15. Inoue Y, Iijima K, Nakamura H, Yoshikawa N. Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 1999;13:33-38.
16. Singh A, Tejani C, Tejani A. One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol. 1999;13:26-32.
17. Hamed RM. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. J Nephrol. 1997;10:266-270.
18. Niaudet P, Habib R. Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc of Nephrol. 1994;5:1049-1056.
19. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc of Nephrol. 1995;5:1820-1825.
20. Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int. 2002;61:1801-1805.
21. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant. 1993;8:1326-1332.
22. Hymes LC. Steroid-resistant, cyclosporine-responsive, relapsing nelphrotic syndrome. Pediatr Nephrol. 1995;9:137-139.
23. Bagga A, Hari P, Moudgil A, Jordan SC. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nelphrotic syndrome. Am J Kidney Dis. 2003;42:1114-1120.
24. Hogg RJ, Fitzgibbons L, Bruick J, Ault B, Baqi N, Trachtman H, Swinford R, on behalf of the Southwest Pediatric Nephrology Group. Clinical trial of mycophenolate mofetil (MMF) for frequent relapsing nephrotic syndrome in children. Pediatr Nephrol. 2004;19:C66 [abstract OFC 18].
25. Gellermann J, Querfeld U. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol. 19:101-104.
26. Jacqz-Aigrain E, Khan Shaghaghi E, Baudouin V, Popon M, Zhang D, Maisin A, Loirat C. Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children. Pediatr Nephrol. 2000;14:95-99.
27. Ettenger RB. New immunosuppressive agents in pediatric renal transplantation. Transplant Proc. 1998;30:1956-1958.